FDA Approves New HIV Treatment for Patients Who Do Not Respond to Existing Drugs
The Food and Drug Administration (FDA) has approved Prezista (darunavir), a new drug for adults whose infection with the human immunodeficiency virus (HIV) has not responded to treatment with other antiretroviral drugs.